Skip to main content
Year archive

RACURA ONCOLOGY LTD — 2018 filings

All 88 regulatory filings released by RACURA ONCOLOGY LTD (RAC) in 2018, sourced directly from the official regulator.

88 Filings
2018 Period
2018 filings (88)
Filing Released Lang
Change of Director's Interest Notice-Dr William Garner 2 pages 27.9KB
Director's Dealing
2018-12-30 English
Change of Director's Interest Notice-Dr William Garner 2 pages 29.2KB
Director's Dealing
2018-12-23 English
Change in substantial holding 2 pages 74.7KB
Major Shareholding Notification
2018-12-23 English
Change in Director's Interest Notice-Peter Molloy 2 pages 26.1KB
Director's Dealing
2018-12-23 English
Change in substantial holding 2 pages 715.0KB
Major Shareholding Notification
2018-12-23 English
Appendix 3B 11 pages 155.3KB
Share Issue/Capital Change
2018-12-20 English
Cleansing Notice 1 page 139.5KB
Capital/Financing Update
2018-12-20 English
Race signs agreement for Bisantrene NPP in Israel 2 pages 113.9KB
Capital/Financing Update
2018-12-16 English
Change of Director's Interest Notice-Dr William Garner 2 pages 27.6KB
Director's Dealing
2018-12-12 English
Change in substantial holding 2 pages 50.5KB
Major Shareholding Notification
2018-12-12 English
Change of Director's Interests Notice-Dr William Garner 2 pages 27.5KB
Director's Dealing
2018-11-26 English
Chairman's AGM Address 2 pages 89.7KB
AGM Information
2018-11-26 English
Managing Director's AGM Presentation 15 pages 584.8KB
AGM Information
2018-11-26 English
Results of Annual General Meeting 2 pages 131.7KB
Declaration of Voting Results & Voting Rights Announcements
2018-11-26 English
Appendix 3B 11 pages 157.1KB
Capital/Financing Update
2018-11-26 English
Change of Director's Interests Notice-Dr John Cullity 2 pages 25.9KB
Director's Dealing
2018-11-26 English
Replacement-Change in substantial holding notice 2 pages 147.4KB
Major Shareholding Notification
2018-11-12 English
Change of Director's Interest Notice-Dr William Garner 3 pages 113.6KB
Director's Dealing
2018-11-11 English
Change in substantial holding 2 pages 73.6KB
Major Shareholding Notification
2018-11-11 English
Race appoints Biosynergy to pursue Bisantrene licensing 3 pages 106.6KB
Capital/Financing Update
2018-10-31 English
Response to ASX Price Query 5 pages 670.2KB
Regulatory Filings
2018-10-31 English
September 2018 Quarterly Report 8 pages 184.7KB
Interim / Quarterly Report Q1 2018
2018-10-25 English
Notice of Annual General Meeting/Proxy Form 34 pages 957.1KB
AGM Information
2018-10-17 English
Annual Report to Shareholders 62 pages 1.6MB
Annual Report FY 2018
2018-10-17 English
Expiry of Unlisted Options 1 page 112.5KB
Capital/Financing Update
2018-09-30 English
RAC appoints US consultant to drive partnering, investment 2 pages 101.3KB
Regulatory Filings
2018-09-30 English
Appendix 3B-Issue of Options 11 pages 162.8KB
Capital/Financing Update
2018-09-30 English
Details of Company Address 1 page 89.2KB
Regulatory Filings
2018-09-27 English
Notification of 2018 Annual General Meeting Date 1
AGM Information
2018-09-27 English
Race signs agreement with NSF Health Sciences to file IND 2 pages 97.0KB
Capital/Financing Update
2018-09-16 English
Change of Director's Interest Notice-Dr William Garner 3 pages 112.8KB
Director's Dealing
2018-09-16 English
Change in substantial holding 2 pages 59.7KB
Major Shareholding Notification
2018-09-16 English
Investor Presentation-Broker Meets Biotech Conference 16 pages 1.2MB
Investor Presentation
2018-09-12 English
Appendix 3Y-Bill Garner 2 pages 27.0KB
Director's Dealing
2018-08-29 English
Appendix 3Y - Peter Molloy 2 pages 25.9KB
Director's Dealing
2018-08-27 English
Management and services changes at Race Oncology 1
Board/Management Information
2018-08-22 English
Appendix 4E & Financial Statements 64 pages 2.7MB
Regulatory Filings
2018-08-20 English
Appendix 4G 10 pages 175.3KB
Governance Information
2018-08-20 English
Investor Presentation 17 pages 1.2MB
Investor Presentation
2018-08-02 English
June 2018 Quarterly Report 9 pages 203.6KB
Interim / Quarterly Report Q4 2018
2018-07-26 English
FDA Grants Bisantrene Rare Paediatric Disease Designation 3 pages 141.7KB
Regulatory Filings
2018-07-17 English
Trading Halt 2 pages 538.2KB
Regulatory Filings
2018-07-15 English
Appendix 3B 11 pages 154.5KB
Capital/Financing Update
2018-07-12 English
Appendix 3B-Issue of Options 11 pages 156.9KB
Capital/Financing Update
2018-07-12 English
Performance Share Milestones Met 1 page 90.8KB
Capital/Financing Update
2018-07-01 English
Expiry of Unlisted Options 1 page 110.9KB
Capital/Financing Update
2018-07-01 English
Appendix 3B 11 pages 157.2KB
Capital/Financing Update
2018-07-01 English
Cleansing Notice 1 page 139.2KB
Capital/Financing Update
2018-07-01 English
Bisantrene poster presented at French Leukaemia Conference 2 pages 116.5KB
Regulatory Filings
2018-06-25 English
Release of Securities from Escrow 1 page 113.5KB
Capital/Financing Update
2018-06-21 English
Bisantrene approval in UK for supply as unlicensed medicine 2 pages 94.2KB
Regulatory Filings
2018-06-20 English
Trading Halt 2 pages 462.1KB
Regulatory Filings
2018-06-19 English
Results of General Meeting 2 pages 130.8KB
Declaration of Voting Results & Voting Rights Announcements
2018-06-19 English
Appendix 3Y - Peter Molloy 2 pages 25.9KB
Director's Dealing
2018-06-17 English
RAC cancer drug success in AML reported by French doctors 3 pages 113.2KB
Regulatory Filings
2018-06-04 English
Expiry of Unlisted Options 1 page 91.2KB
Capital/Financing Update
2018-06-03 English
Notice of General Meeting/Proxy Form 19 pages 728.3KB
Proxy Solicitation & Information Statement
2018-05-16 English
Race executes agreement for Bisantrene clinical trial 2 pages 248.3KB
Regulatory Filings
2018-05-14 English
Race appoints Oncologist to head Medical Affairs 3 pages 118.5KB
Board/Management Information
2018-05-14 English
Interview with Dr John Cullity 2 pages 112.1KB
Board/Management Information
2018-05-06 English
Investor Update 4 pages 129.9KB
Capital/Financing Update
2018-04-29 English
Appendix 3Y-Bill Garner 2 pages 27.1KB
Director's Dealing
2018-04-26 English
Appendix 4C - quarterly 5 pages 83.6KB
Interim / Quarterly Report Q3 2018
2018-04-19 English
Appendix 3B 11 pages 155.2KB
Share Issue/Capital Change
2018-04-12 English
Cleansing Notice 1 page 137.9KB
Share Issue/Capital Change
2018-04-12 English
Race signs global distribution agreement with Durbin PLC 2 pages 112.1KB
Capital/Financing Update
2018-04-10 English
Initial Director's Interest Notice 2 pages 70.4KB
Director's Dealing
2018-04-05 English
Race appoints former Sanofi executive to the Board 2 pages 113.3KB
Board/Management Information
2018-04-03 English
Final Director's Interest Notice 2 pages 174.3KB
Director's Dealing
2018-04-03 English
Change in substantial holding 2 pages 159.8KB
Major Shareholding Notification
2018-03-19 English
Appendix 3B-Placement 11 pages 155.4KB
Capital/Financing Update
2018-03-18 English
Cleansing Notice 1 page 102.3KB
Share Issue/Capital Change
2018-03-18 English
Race increases placement to $3.69m 1 page 89.2KB
Capital/Financing Update
2018-03-15 English
Race completes over-subscribed $3.159 million placement 2 pages 112.7KB
Capital/Financing Update
2018-03-11 English
Trading Halt 2 pages 191.0KB
Capital/Financing Update
2018-03-06 English
Appendix 3B 11 pages 155.3KB
Capital/Financing Update
2018-02-26 English
Section 708A Notice 1 page 138.1KB
Share Issue/Capital Change
2018-02-26 English
Second Bisantrene Patent Allowed in US 2 pages 111.2KB
Regulatory Filings
2018-02-20 English
Appendix 4D & Half-Year Financial Statements 23 pages 803.3KB
Interim / Quarterly Report H1 2018
2018-02-19 English
Race Oncology Investor Presentation February 2018 19 pages 3.0MB
Investor Presentation
2018-02-08 English
Appendix 3B 11 pages 155.2KB
Capital/Financing Update
2018-02-08 English
Section 708A Notice 1 page 138.1KB
Capital/Financing Update
2018-02-08 English
Appendix 4C - quarterly 5 pages 97.0KB
Interim / Quarterly Report Q2 2017
2018-01-30 English
Notice of Allowance for Bisantrene Patent in US 2 pages 113.3KB
Capital/Financing Update
2018-01-28 English
Race Receives $170k R&D Tax Incentive Refund 1 page
Regulatory Filings
2018-01-23 English
Appendix 3B 11 pages 155.1KB
Capital/Financing Update
2018-01-10 English
Section 708A Notice 1 page 136.8KB
Share Issue/Capital Change
2018-01-10 English
Race to Present at JP Morgan Biotech Conference in US 20 pages 1.3MB
Investor Presentation
2018-01-03 English